The Skin Diseases Research Center at the University of Wisconsin (UWSDRC) has collected 40 outstanding investigators from 16 Departments, 5 Schools and 7 Centers, all engaged in cutaneous cell death and differentiation research. The UW-Madison is an institution renowned for its academic environment which is conducive to innovative interdisciplinary approaches to biomedical research and education. All members of the UWSDRC have active research programs relevant to cutaneous biology and a broad range of skin diseases. UWSDRC investigators leverage $4.3M of annual direct support ($1.5M from NIAMS) to advance cutaneous cell death and differentiation research. The UWSDRC will be based in the Department of Dermatology to which the School of Medicine and Public Health made a major commitment when it recruited the proposed UWSDRC Director, Gary S. Wood, and Associate Director, Hasan Mukhtar. Major resources have been incorporated into Dermatology including departmental status, seven tenure-track faculty positions, 56,000 SF of space, start-up and retention packages, and more than $10M in endowments devoted exclusively to supporting research. Beginning with no extramural support in 2001, Dermatology has consistently ranked among the top 10-20 NIH skin disease research programs for several years. If the UWSDRC is funded, the Dean, UW Institute for Clinical and Translational Research (ICTR) and Department of Dermatology will commit an additional 1,600 SF of new space and up to $2.2M to supplement the NIH funds. The UWSDRC will contain an Administrative Core and 3 service cores (Cell Culture Core (CCC), Experimental Cutaneous Pathology Core (ECPC) and Evolving Technology Core (ETC)) as well as an Enrichment Program including pilot and feasibility studies, visiting professors, mentoring and gender/minority awareness. The UWSDRC will maximize performance and resources by coordinating with a wide array of existing UW-Madison core facilities and Department of Dermatology programs.
Skin diseases account for significant morbidity and mortality in the USA and worldwide. Creation of the Skin Diseases Research Center at the University of Wisconsin (UWSDRC) will provide important new resources to advance research and bring together 40 investigators from across the UW-Madison campus for greater collaboration in the fight against skin diseases.
|Rady, Islam; Bloch, Melissa B; Chamcheu, Roxane-Cherille N et al. (2018) Anticancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review. Oxid Med Cell Longev 2018:1826170|
|Karrys, Amitis; Rady, Islam; Chamcheu, Roxane-Cherille N et al. (2018) Bioactive Dietary VDR Ligands Regulate Genes Encoding Biomarkers of Skin Repair That Are Associated with Risk for Psoriasis. Nutrients 10:|
|Rodríguez, Carlos I; Castro-Pérez, Edgardo; Longley, B Jack et al. (2018) Elevated cyclic AMP levels promote BRAFCA/Pten-/- mouse melanoma growth but pCREB is negatively correlated with human melanoma progression. Cancer Lett 414:268-277|
|Khan, Mohammad Imran; Rath, Suvasmita; Adhami, Vaqar Mustafa et al. (2018) Hypoxia driven glycation: Mechanisms and therapeutic opportunities. Semin Cancer Biol 49:75-82|
|Meyers, Jordan M; Grace, Miranda; Uberoi, Aayushi et al. (2018) Inhibition of TGF-? and NOTCH Signaling by Cutaneous Papillomaviruses. Front Microbiol 9:389|
|Chhabra, Gagan; Garvey, Debra R; Singh, Chandra K et al. (2018) Effects and Mechanism of Nicotinamide Against UVA- and/or UVB-mediated DNA Damages in Normal Melanocytes. Photochem Photobiol :|
|Chamcheu, Jean Christopher; Siddiqui, Imtiaz A; Adhami, Vaqar M et al. (2018) Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis. Int J Nanomedicine 13:4189-4206|
|Rank, Leslie A; Walsh, Naomi M; Lim, Fang Yun et al. (2018) Peptide-Like Nylon-3 Polymers with Activity against Phylogenetically Diverse, Intrinsically Drug-Resistant Pathogenic Fungi. mSphere 3:|
|Zhao, Lei; Okhovat, Jean-Phillip; Hong, Eric K et al. (2018) Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma. Neoplasia 21:82-92|
|Denu, Ryan A; Shabbir, Maria; Nihal, Minakshi et al. (2018) Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma. Mol Cancer Res 16:517-527|
Showing the most recent 10 out of 31 publications